Research Article
Synthesis, Characterization, and Antibacterial Activity of Biocompatible Aluminium Complexes with N-(2-Hydroxy-5-methyl benzyl)phenylalanine
Table 3
Results of antibacterial activity of the synthesized compounds.
| 1/1a–1c | Con.c. (mg/mL)a | The radius of the zone of inhibition (mm) | P. aeruginosa (MTCC-424) | S. aureus (MTCC-103) | K. pneumoniae (MTCC-3389) | K. pneumoniae (MTCC-109) |
| 1 | 1/5/15/50 | 0.85/0.85/1.1/1.25 | 0/0/0.35/0.85 | 0/0.25/0.45/0.70 | 0.45/0.40/0.90/1.25 | 1a | 1/5/15/50 | 0.05/0.70/0.75/1.25 | 0/0.0/0.35/0.75 | 0/0/0.30/0.70 | 1.25/0.45/0.75/1.25 | 1b | 1/5/15/50 | 0.45/0.75/0.80/1.25 | 0/0.45/0.20/0.80 | 0/0/0/0.55 | 0.0/0.75/0.95/1.30 | 1c | 1/5/15/50 | 0.55/0.60/0.75/1.25 | 0/0.25/0.25/0.75 | 0/0/0/0.75 | 0.45/0.70/0.95/1.45 | DMSO | — | 0/0/0/0 | 0/0/0/0 | 0/0/0/0 | 0/0/0/0 |
|
|
a1/5/15 mg/mL con.c were taken for each ligand and aluminium complexes with positive control of 50 mg/mL oxytetracycline.
|